Details for New Drug Application (NDA): 079013
✉ Email this page to a colleague
NDA 079013 describes ALFUZOSIN HYDROCHLORIDE, which is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Invagen Pharms, Norvium Bioscience, Sun Pharm, Torrent Pharms, Unichem, and Wockhardt, and is included in nine NDAs. It is available from ten suppliers. Additional details are available on the ALFUZOSIN HYDROCHLORIDE profile page.
The generic ingredient in ALFUZOSIN HYDROCHLORIDE is alfuzosin hydrochloride. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the alfuzosin hydrochloride profile page.
The generic ingredient in ALFUZOSIN HYDROCHLORIDE is alfuzosin hydrochloride. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the alfuzosin hydrochloride profile page.
Summary for 079013
| Tradename: | ALFUZOSIN HYDROCHLORIDE |
| Applicant: | Apotex Inc |
| Ingredient: | alfuzosin hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 079013
| Mechanism of Action | Adrenergic alpha-Antagonists |
Suppliers and Packaging for NDA: 079013
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ALFUZOSIN HYDROCHLORIDE | alfuzosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079013 | ANDA | Apotex Corp. | 60505-2850 | 60505-2850-9 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-2850-9) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MG | ||||
| Approval Date: | Jul 18, 2011 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
